Navigation Links
INSYS Therapeutics, Inc. Announces Positive Phase III Efficacy Trial Results for Fentanyl Sublingual Spray
Date:3/8/2010

PHOENIX, March 9 /PRNewswire/ -- INSYS Therapeutics, Inc. announces positive results from the pivotal phase III efficacy trial for patients utilizing the Fentanyl Sublingual Spray (SL Spray) technology to treat breakthrough cancer pain.  All primary and secondary endpoints were achieved in the study, and the drug is the first product to ever show statistically significant pain relief when measuring the summary of pain intensity difference at five minutes (SPID(5)) in a phase III breakthrough cancer pain trial using Fentanyl.

The primary endpoint of the study was to measure the summary of pain intensity difference at thirty minutes (SPID (30)) compared to placebo.  INSYS' SL Spray significantly improved mean SPID (30) scores compared with placebo (p<0.0001).  The SL spray significantly improved mean SPID values compared with placebo as early as 5 minutes (p=0.022), while all other endpoints starting at ten minutes showed the p value remaining at or less than 0.0001.  Given breakthrough cancer pain's rapid onset and often peak intensity at three to five minutes, it is vital to provide patients with a faster onset of action.


'/>"/>
SOURCE INSYS Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Clinsys(R) TPS Teams Provide Comprehensive Clinical Development Plans
2. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
3. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
4. Cell Therapeutics, Inc. (CTI) Supports Panel Discussion on Women and Lung Cancer on Capitol Hill
5. Velcura Therapeutics, Inc. Reports Positive Pre-IND Meeting With FDA and Plans Early Clinical Trials for New Drug to Treat Multiple Myeloma Bone Disease
6. NIST Awards $2 Million to Velcura Therapeutics, Inc. for Innovative Technology R&D - Dual-Action Therapies for Bone Disease
7. Ocera Therapeutics, Inc. Completes Enrollment in FHAST1, a Pivotal Phase 3 Clinical Trial in Fistulizing Crohns Disease
8. William R. Ringo Joins Hyperion Therapeutics, Inc. Board of Directors as Chairman
9. Cell Therapeutics, Inc. (CTI) Submits European Marketing Authorization Application for XYOTAX(TM)
10. Dynamis Therapeutics, Inc. Discovers RAGE Inhibitor
11. Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... VIEW, Calif. , Feb. 26, 2015  IRIDEX Corporation ... release its fourth quarter and full year 2014 financial results ...   In conjunction with the release, the Company will host ... p.m. Eastern Time on Thursday, March 5, 2015 ... business developments. Interested parties may access the live ...
(Date:2/26/2015)... Feb. 26, 2015 Every year many millions ... fight heart disease.  Nevertheless, year after year doctors and ... as the first test to determine the status of ... pain or not, even though that technology is over ... fact that doctors know, (while most patients do not ...
(Date:2/26/2015)... , Feb. 26, 2015  Spring Bank Pharmaceuticals, ... for the treatment of Hepatitis B virus (HBV) ... of a $22 million financing. Funds from this ... a novel, broad spectrum antiviral agent derived from ... hybrid (SMNH) chemistry platform, into Phase II clinical ...
Breaking Medicine Technology:IRIDEX Announces Fourth Quarter and Full Year 2014 Conference Call and Release Date 2National Heart Health Month In February 2Spring Bank Pharmaceuticals Completes $22 Million Financing 2
... Pharmaceuticals, Inc. (NYSE Amex: INO ), a ... against cancers and infectious diseases, announced today the publication ... Vaccines detailing potent immune responses in a preclinical ... targeting two antigens. While current prostate cancer therapies target ...
... Feb. 1, 2011 Anthera Pharmaceuticals, Inc. (Nasdaq: ... treat serious diseases associated with abnormal auto-immune responses and ... Thompson to its Board of Directors. Currently, Dr. Thompson ... founder and Managing Director of Strategicon Partners, an investment ...
Cached Medicine Technology:Inovio Pharmaceuticals' Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial 2Inovio Pharmaceuticals' Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial 3Inovio Pharmaceuticals' Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial 4Inovio Pharmaceuticals' Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial 5Dr. Peter Thompson Joins Anthera Pharmaceuticals Board of Directors 2
(Date:2/26/2015)... 2015 A Beautiful Smile Dentistry is ... offering the following 50 year celebration specials to their ... of Sonic Care Diamond Clean or the Braun Oral ... The cost is $2895 for the Invisalign special (this ... ten treatment procedures are priced accordingly). The practice ...
(Date:2/26/2015)... 2015 2015 marks five years of ... David Caggiano! , Orthodontics is a perfect blend ... his background in biomedical engineering, his artistic talent, his ... general dentist allows Dr. Caggiano to create innovative approaches ... was named Orthodontic Products’ Best of 2012, a national ...
(Date:2/26/2015)... 2015 The hip resurfacing procedure ... Central Texas resident John Short to resume his active lifestyle, ... out to climb Mt. Kilimanjaro, the highest free-standing mountain in ... , Starting in his late 20s, Short suffered from early ... bones and sockets were bone on bone. , Then ...
(Date:2/26/2015)... Beckman Coulter is sponsoring a new ... cargo in cell-to-cell communication,” which will focus on the ... communication. The webinar is free to attend and will ... , Every cell in the body can release several ... “exosomes” or “microvesicles.” These vesicles carry a wide array ...
(Date:2/26/2015)... Dallas, Texas (PRWEB) February 26, 2015 ... Hemostat Industry is a professional and in-depth study ... Hemostat industry with a focus on the ... market research are Lawton Gmbh & Co.KG, Hu-Friedy, ... Shanghai Medical Instruments, Shuangyin, Shanghai Weirong Medical Equipment, ...
Breaking Medicine News(10 mins):Health News:A Beautiful Smile Dentistry is Celebrating 50 Years in Practice! 2Health News:A Beautiful Smile Dentistry is Celebrating 50 Years in Practice! 3Health News:Dr. David Caggiano of Caggiano Orthodontics is Celebrating Five Years as an "NJ Top Dentist" ! 2Health News:Dr. David Caggiano of Caggiano Orthodontics is Celebrating Five Years as an "NJ Top Dentist" ! 3Health News:Hip Resurfacing at Texas Orthopedics Enables Patient to Climb Mt. Kilimanjaro 2Health News:Hip Resurfacing at Texas Orthopedics Enables Patient to Climb Mt. Kilimanjaro 3Health News:Beckman Coulter Webinar Series Presents Diversity of Extracellular Vesicles and Their Cargo in Cell-to-cell Communication 2Health News:Beckman Coulter Webinar Series Presents Diversity of Extracellular Vesicles and Their Cargo in Cell-to-cell Communication 3Health News:Global Hemostat Industry Data, Size and Growth Report 2015-2020 Now Available at DeepResearchReports.com 2Health News:Global Hemostat Industry Data, Size and Growth Report 2015-2020 Now Available at DeepResearchReports.com 3
... Easter Seals was recently awarded a,$100,000 grant ... support its,workforce development program, Operation Employ Veterans., ... Foundation,s Operation,Healing Freedom campaign, providing training to ... retain wounded veterans across the,Chicagoland area. Area ...
... of Seniors Satisfied with Medicare Drug,Benefit, WASHINGTON, Nov. ... to raise awareness about the 2009,Medicare prescription drug coverage ... 31, 2008., The campaign is designed to encourage ... Part D program if they have not,already done so, ...
... support programs with which Highmark employees ... ... recently awarded,$9,500 to 19 nonprofit organizations in Pennsylvania to support programs,with ... activity, provide nature, arts and culture education,and raise funds to provide ...
... Ten Emerging Technologies That Will Shape Healthcare Next ... ... if a simple blood test could,detect recurrent cancer earlier, while also predicting ... cards could help a,paraplegic breathe without a bulky ventilator. Or imagine if ...
... create predictive models of human disease is likely ... Foundation (ESF), which urged for a collaborative effort ... produces an enormous amount of data from different ... screening of human tissue, and in vitro laboratory ...
... Heart failure patients who regularly exercise fare better ... patients who do not work out on a regular ... The findings, reported today at the annual meeting of ... long way toward addressing concerns about the value of ...
Cached Medicine News:Health News:Easter Seals Awarded $100,000 McCormick Foundation Grant to Help Employ Wounded Veterans 2Health News:Easter Seals Awarded $100,000 McCormick Foundation Grant to Help Employ Wounded Veterans 3Health News:Medicare Today Launches National Medicare Prescription Drug Enrollment Awareness Campaign 2Health News:Medicare Today Launches National Medicare Prescription Drug Enrollment Awareness Campaign 3Health News:Medicare Today Launches National Medicare Prescription Drug Enrollment Awareness Campaign 4Health News:Highmark Employee Volunteers Receive $9,500 in Grants for Nonprofit Organizations 2Health News:Highmark Employee Volunteers Receive $9,500 in Grants for Nonprofit Organizations 3Health News:Highmark Employee Volunteers Receive $9,500 in Grants for Nonprofit Organizations 4Health News:Highmark Employee Volunteers Receive $9,500 in Grants for Nonprofit Organizations 5Health News:Highmark Employee Volunteers Receive $9,500 in Grants for Nonprofit Organizations 6Health News:Cleveland Clinic Unveils 'Top 10' Medical Innovations for 2009 2Health News:Cleveland Clinic Unveils 'Top 10' Medical Innovations for 2009 3Health News:Cleveland Clinic Unveils 'Top 10' Medical Innovations for 2009 4Health News:Cleveland Clinic Unveils 'Top 10' Medical Innovations for 2009 5Health News:Computers make sense of experiments on human disease 2Health News:Computers make sense of experiments on human disease 3Health News:Exercise improves quality of life for heart failure patients 2Health News:Exercise improves quality of life for heart failure patients 3
Stryker Leibinger offers a variety of different Titanium Implant Systems and special instrument sets, which enable our customers to treat a wide range of indication...
Stryker Leibinger offers a variety of different Titanium Implant Systems and special instrument sets, which enable our customers to treat a wide range of indication...
... BiStim provides an effective upgrade path ... of the Magstim 200 modularity. The potential ... paired pulse stimulation through a single stimulating ... and to control independently the power level ...
... Magstim design the new Magstim 200 monophasic ... knowledge and expertise gathered in both the ... innovative design that will help further establish ... of preferred choice. Ergonomic modular approach ...
Medicine Products: